Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Non-contained Infrabony Defects With Enamel Matrix Derivative Alone or in Combination With HA/β-TCP Graft: a 12-month Randomized Controlled Clinical Trial

NCT02828423 is registered in ClinicalTrials.gov with Universitat Internacional de Catalunya as lead sponsor.

NCT NCT02828423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02828423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Non-contained Infrabony Defects With Enamel Matrix Derivative Alone or in Combination With HA/β-TCP Graft: a 12-month Randomized Controlled Clinical Trial
Lead sponsor
Universitat Internacional de Catalunya
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2011
Completion date
March 31, 2016
Enrollment
52 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intrabony periodontal defect